Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR and KRAS Mutations in Triple-Mutated Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jul 2017

Yoshida Ryohei, Sasaki Takaaki, Ohsaki Yoshinobu

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ErbB Receptors
Share to EGFR gene
Share to KRAS gene
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 28629545
DOI: 10.1016/j.jtho.2017.02.022

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR and KRAS Mutations in Triple-Mutated Lung Cancer.PMID 28629545Read ↗

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitorsSemantic proximity Read ↗

EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.Semantic proximity Read ↗

EGFR Mutations and Lung CancerSemantic proximity Read ↗

Different co-mutations in triple EGFR mutated adenocarcinomas in a patient.Semantic proximity Read ↗

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers.Semantic proximity Read ↗

EGFR mutations and EGFR tyrosine kinase inhibitors.Semantic proximity Read ↗

Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors.Semantic proximity Read ↗

EGFR mutations in squamous cell lung cancer in never-smokers.Semantic proximity Read ↗

Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.Semantic proximity Read ↗

Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung AdenocarcinomasSemantic proximity Read ↗

Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.